Business
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs.
Novo Nordisk on Sunday announced that prescriptions of the Wegovy pill have topped 3 million since it entered the U.S. market about five months ago. The Danish drugmaker’s CEO Mike Doustdar celebrated the milestone, saying in an interview with CNBC that Novo was able to accelerate prescriptions even as Lilly introduced its own GLP-1 pill in April.
“If that’s not acceleration, then I don’t know what is,” Doustdar told CNBC this weekend at the American Diabetes Association’s Scientific Sessions.
Meanwhile, Lilly CEO Dave Ricks told CNBC that prescriptions of its pill Foundayo are “markedly higher” than the 20,000 that Lilly reported about six weeks ago around its first-quarter earnings release, without giving a specific number. He said the number builds week over week and that Lilly is pleased with the progress.
The competition for the weight loss pill market is only the latest for the longtime rivals. Signs of that tension were evident throughout the industry event this weekend. Cars drove around advertising Novo’s Wegovy pill, while pictures of Lilly’s Foundayo pill covered some of the floors of the convention center in New Orleans.
And the two companies will soon make their case for their daily pills and their weekly shots to seniors. Starting in July, millions of people with Medicare will be able to access GLP-1 drugs for weight loss for $50 a month. Until now, Medicare beneficiaries have had to pay out of pocket for the obesity drugs, costing them potentially hundreds of dollars a month. Both companies say they’re focused on raising awareness of the program, though they have different pitches.
Weight loss pills available: A heap of GLP-1 pills
Aprott | Istock | Getty Images
Doustdar thinks the program could be an opportunity to regain some of the ground Novo’s Wegovy shot has lost to Lilly’s Zepbound. The drugmaker plans to advertise Wegovy’s other health benefits on its label, he said, like the fact that it can decrease the risk of cardiovascular problems like heart attacks and strokes. He said Novo should win with seniors “if common sense is to prevail, and I put myself in their shoes.”
“With the Wegovy high dose, why would you not take a product that has the same efficacy, percentage wise, than my competitor?” he said. “On top of it, you get kidney, liver, heart, stroke protection, let’s say free of charge. I would take it if I was 10 years older.”
Lilly’s pitch to seniors is convenience. The company’s pill Foundayo can be taken at any time of day with food, water and other medicines, whereas Novo’s pill needs to be taken on an empty stomach with little water and requires fasting for 30 minutes afterward.
“The main thing is, it’s easy,” Ricks said. “This is something that can just go in your daily routine. Most seniors are on many other medications, and they’ve got their pill case, and they use that every day, and this will just fit right into that without any extra thought.”
Ricks said Lilly is working closely with the government to prepare, and he’s confident that Humana, which will process prescription requests, will do a good job. He thinks the program will be popular with seniors and that longer term, the initiative could help prove that obesity care should be “regular health care.”
“We have to prove that in this pilot and prove cost effectiveness and then kind of reset what we expect from our health insurance, which is obesity care should be health care,” Ricks said.
Lilly and Novo are trying to increase insurance coverage of GLP-1 drugs for obesity. At least one analysis found the drugs to be cost effective, but employers have balked at paying for them because so many people could be eligible for the treatments and many patients stop them after achieving a weight loss goal. Health insurance company Cigna last week said it would stop covering the medicines for its own employees.
At Lilly, less than 20% of the company’s beneficiaries are using the drugs for weight loss, and people are staying on them, Ricks said. Lilly is conducting an internal study to measure its health costs and outcomes like hospitalization rate, progression to diabetes and cardiovascular events. Lilly plans to publish those results later this year, he said.
The next stage in the GLP-1 race
While they prepare for Medicare coverage, both companies are trying to introduce more drugs to treat obesity. At the conference this weekend, Lilly presented Phase 3 data for retatrutide, an experimental triple agonist that helped people lose an average of 28% of their body weight when they stayed on the drug. Nearly half of people lost more than 30% of their body weight, an amount that’s similar to bariatric surgery. The drug also helped improve related conditions like knee osteoarthritis and sleep apnea.
Initially, Ricks expects retatrutide to primarily be used to treat people with higher body mass indexes, or BMI. He also sees promise for the second-lowest strength of the drug. It helped people lose an average of 19% of their body weight with fewer side effects than the higher strengths.
One question was whether Lilly would make retatrutide available on its direct-to-consumer sales platform LillyDirect once it’s approved by the Food and Drug Administration because it’s so powerful. Lilly “absolutely” plans to make the drug available there, Ricks said.
For Novo, the next drug on the horizon is called CagriSema. It combines the main ingredient of Wegovy with another molecule called cagrilintide, which mimics another hormone called amylin. The drug’s efficacy has underwhelmed investors since it has showed weight loss that is similar to Lilly’s Zepbound and less than Lilly’s retatrutide. Doustdar thinks the drug’s edge in effectiveness over Wegovy, even if only a few percentage points, is meaningful, and said he’s committed to launching CagriSema. Novo expects an approval decision from the U.S. Food and Drug Administration on the drug in the fourth quarter of this year.
“If I have to forget about CagriSema, a lot of other products have to be forgotten about as well,” Doustdar said. “I don’t think it should work that way.”
Doustdar took over as chief executive almost one year ago after a major shakeup that led to the departure of the company’s former leader and thousands of employees being laid off. He’s tasked with reinvigorating sales of Wegovy, the company’s pipeline and its stock price. Eventually, he said Novo will be more diversified within the area of cardiometabolic health — like diabetes and obesity — and some of the “adjacencies.”
In the meantime, Doustdar said the early success of the Wegovy pill has helped Novo regain some momentum.
“The pill was a great example of people getting confident that we can do this, that at Novo Nordisk, better days are ahead of them and not just behind,” he said. “So we also have to really make sure that we turn these positive moments that right now we’re in into a longer term trend, so we gain the trust day by day and improve that both internally as well as, of course, externally, and I will work hard to make sure that this continues.”
Business
Betterware: Tupperware's New Numbers Offer Early Encouragement
Betterware: Tupperware's New Numbers Offer Early Encouragement
Business
I Am Buying +10% Yields At Big Discounts To Boost My Income
Rida Morwa is a former investment and commercial Banker, with over 35 years of experience. He has been advising individual and institutional clients on high-yield investment strategies since 1991. Rida Morwa leads the Investing Group High Dividend Opportunities where he teams up with some of Seeking Alpha’s top income investing analysts. The service focuses on sustainable income through a variety of high yield investments with a targeted safe +9% yield. Features include: model portfolio with buy/sell alerts, preferred and baby bond portfolios for more conservative investors, vibrant and active chat with access to the service’s leaders, dividend and portfolio trackers, and regular market updates. The service philosophy focuses on community, education, and the belief that nobody should invest alone. Learn More.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of THW, USA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Beyond Saving, Philip Mause, and Hidden Opportunities, all are supporting contributors for High Dividend Opportunities. Any recommendation posted in this article is not indefinite. We closely monitor all of our positions. We issue Buy and Sell alerts on our recommendations, which are exclusive to our members.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
Lula calls new US tariffs a mistake in Washington Post op-ed

Lula calls new US tariffs a mistake in Washington Post op-ed
Business
Trump Calls LeBron James a Possible ‘Racist’ While Praising Michael Jordan as the Real GOAT in Oval Office
President Donald Trump said Friday that he considers LeBron James a possible “racist” while declaring Michael Jordan the greatest basketball player of all time, remarks that came hours after James announced he would play for the Philadelphia 76ers this coming season.
A GOAT debate with a political twist
Speaking to reporters in the Oval Office, Trump was asked to weigh in on the long-running debate over whether James or Jordan deserves the title of basketball’s greatest player ever. Rather than addressing statistics, championships or on-court accomplishments, Trump framed his answer around his personal relationship with each player. Speaking about Jordan, Trump described their friendship directly. “Michael Jordan is a guy that’s a friend of mine. Play golf with him. He’s a really good guy,” Trump said.
Turning to James, Trump’s tone shifted sharply. According to Yahoo Sports, Trump said, “I think LeBron is, maybe he’s a racist. But maybe he doesn’t like Trump I don’t know.” He went on to justify his preference for Jordan on personal terms rather than basketball merit, concluding that his ranking came down to who liked him personally rather than any evaluation of the players’ careers.
A history of friction between Trump and James
Friday’s comments extend a yearslong pattern of public friction between Trump and James that dates back to Trump’s first term in office. According to The Hill, the two have clashed repeatedly over the years, including a notable 2018 exchange in which James criticized Trump’s approach to leadership. Reacting to Trump’s rhetoric at the time, James suggested the president’s comments no longer surprised him, saying, “It’s not even a surprise when he says something.”
Other accounts of the relationship point to additional flashpoints. According to Thought Catalog, James previously called Trump a “bum” after the president rescinded a planned White House invitation to the Golden State Warriors during an earlier NBA championship season, a decision James publicly criticized at the time. Trump later mocked James’ intelligence on social media in a separate incident, drawing public pushback that included support for James from Jordan himself, according to the same report.
James has also been an outspoken advocate on issues including police violence and has publicly criticized several of Trump’s political campaigns over the years, positioning him among the more politically vocal athletes in professional sports.
Timing tied to James’ move to Philadelphia
Trump’s comments came just hours after James confirmed he would sign with the Philadelphia 76ers, ending speculation about where the 41-year-old superstar would play in what is expected to be one of the final stretches of his 23-season NBA career. The timing led several reporters to ask Trump directly about the news during his Oval Office appearance, prompting the exchange over the GOAT debate.
James’ move to Philadelphia came after he bypassed potential reunions with both the Miami Heat and the Cleveland Cavaliers, two franchises where he previously won championships, in favor of joining a 76ers roster built around Joel Embiid, Tyrese Maxey and Jaylen Brown.
A long-standing basketball debate reframed
The Jordan-versus-James debate has divided NBA fans for years, typically centered on statistical comparisons, championship counts and eras of competition rather than personal relationships. James has won four NBA titles and four MVP awards across his 23 seasons, a career that has included stops with the Cavaliers, Miami Heat, Los Angeles Lakers and now the 76ers. Jordan won six championships and five MVP awards during 13 seasons with the Chicago Bulls in the 1980s and 1990s, along with a brief comeback with the Washington Wizards in the early 2000s. Other NBA figures, including Kareem Abdul-Jabbar and Magic Johnson, are also occasionally floated in broader GOAT conversations, though Jordan and James remain the two most frequently debated candidates.
Trump’s decision to base his answer on personal friendship rather than on-court accomplishments marked a departure from how the debate is typically framed among basketball analysts and fans, drawing attention less for the substance of his pick and more for the accusation he leveled against James in the process.
Reaction and criticism
Trump’s remarks quickly circulated widely online, drawing criticism from commentators who noted the irony of Trump raising concerns about racism given his own history of controversial remarks touching on race, including past comments about African nations and immigrants that were widely condemned as racist, as well as his promotion of unfounded claims questioning the citizenship of former President Barack Obama, the nation’s first Black president. Critics argued that Trump’s comment reflected a pattern of dismissing critics or perceived opponents through personal attacks rather than substantive engagement.
No immediate response from James
As of Friday, James had not publicly responded to Trump’s comments. Representatives for James and the 76ers did not immediately address the remarks either. Given the two men’s history of public exchanges over the years, further response from James or his camp remains possible in the days ahead, though none had surfaced by the time Trump’s comments began circulating widely online.
For now, Trump’s remarks have added a political dimension to a debate that traditionally centers on basketball performance rather than personal relationships or political alignment. Whether James addresses the comments directly, following a pattern of past exchanges between the two, or lets the moment pass without response, remains to be seen as he prepares to begin his tenure with the 76ers this coming season.
Business
Wildfires threaten Bordeaux as France, Spain battle blazes

Wildfires threaten Bordeaux as France, Spain battle blazes
Business
Shein swings to quarterly loss ahead of Hong Kong IPO

Shein swings to quarterly loss ahead of Hong Kong IPO
Business
AT&T: 6.7% Yielding Debt Remains Very Attractive
AT&T: 6.7% Yielding Debt Remains Very Attractive
Business
14 penny stocks plunge up to 70% in 3 months. Are you affected? – Under Pressure
Over the past three months, 15 penny stocks have witnessed sharp corrections, with declines ranging from 25% to 70%. These underperformers were identified through a screen focusing on stocks with a market capitalisation below Rs 1,000 crore, a share price under Rs 20, and a minimum recent trading volume of 5 lakh shares. The screen highlights low-priced, relatively liquid penny stocks that have come under significant selling pressure during this period. (Data Source: ACE Equity)
Although penny stocks often attract investors with their low entry prices and potential for rapid gains, they come with substantial risks. Due to low liquidity, high volatility, and limited transparency, they are prone to manipulation and sudden price drops. Without a clear strategy and strong risk controls, investors may face more losses than gains.
Business
(PHOTO) Jessica Alba Turns Heads in Cheeky Bouguessa Micro Minidress During Stylish New York City Outing
Jessica Alba brought a bold, high-fashion moment to New York City this week, sharing images from a recent trip to the city on social media that showcased a carefully layered evening look built around a micro minidress from designer label Bouguessa.
A layered, high-fashion look
In the photos, Alba wore a strapless black micro minidress from Bouguessa, a design that cut straight across the bust and hugged her figure closely, with a hemline that sat high on her thighs. Rather than leaving the look as a simple little black dress, Alba layered a sheer black midi skirt from The Frankie Shop underneath the minidress, allowing the translucent fabric to peek out beneath the short hemline and add texture and movement to the overall silhouette. The combination created a style that blended a daring, cropped centerpiece with a more fluid, elongated layer beneath it, a pairing fashion outlets described as both sophisticated and unexpected.
Alba completed the outfit with black strappy thong heels from Favorite Daughter, a minimalist choice that elongated her legs and matched the sleek tone of the rest of the ensemble. She accessorized with fine gold chain necklaces and a delicate bracelet, adding subtle shine without overwhelming the outfit’s clean lines. For the accompanying photos, Alba wore her caramel-blonde hair styled straight, with soft, face-framing layers resting near her collarbone, paired with warm bronzed makeup and a nude lip for a polished, understated finish. Her caption referenced a memorable weekend spent in New York City, though she did not specify the occasion tied to the outing.
Part of a broader run of high-profile style moments
The New York appearance adds to a string of recent fashion moments for Alba, who has increasingly used social media to showcase her personal style outside of red carpet events. Fashion outlets have highlighted a series of standout looks from Alba in recent months, including a plunging, high-slit Aritzia dress and other figure-forward pieces that have drawn attention for blending bold silhouettes with polished styling.
A career built well beyond acting
While Alba remains widely known for her acting career, including roles in “Fantastic Four,” “Sin City” and “Honey,” her public profile in recent years has increasingly reflected her business background as well. Alba founded consumer goods company The Honest Company in 2012, building it into a major personal care and baby products brand before taking it public on the Nasdaq in 2021, a milestone that made her the youngest Latina to take a company public through an IPO. She served as the company’s chief creative officer for over a decade before stepping down from that leadership role, while remaining on Honest’s board of directors to continue providing strategic guidance.
Beyond Honest, Alba has built a broader career as an entrepreneur and public figure. She authored the New York Times bestseller “The Honest Life,” has served on the boards of Yahoo, the LA28 Olympic and Paralympic Games organizing committee, and children’s nonprofit Baby2Baby, and continues to appear in film and television projects, including co-hosting the Roku unscripted series “Honest Renovations,” which is heading into its fourth season. Earlier this year, Alba signed with talent agency CAA, adding to her existing representation, a move that reflected her continued active presence across both entertainment and business ventures.
Personal life developments
Alba’s public profile has also been shaped by personal changes over the past year and a half. She and her former husband, film producer Cash Warren, announced their separation in January 2025 after 16 years of marriage, and the couple has since finalized their divorce. Alba and Warren share three children: Honor, 17, Haven, 14, and Hayes, 8. Since the split, Alba has been in a relationship with actor Danny Ramirez, whom she began dating in July 2025. The couple has been seen publicly on several occasions since, including a romantic getaway that Alba shared with fans on social media.
A recognizable presence in entertainment and fashion
Alba’s willingness to experiment with bold, high-fashion styling has become a recurring theme in her public image in recent months, with outlets covering her looks framing them as evidence of her continued relevance in both the entertainment and fashion spaces, more than two decades into her career. Her latest New York City appearance, built around the Bouguessa minidress and layered Frankie Shop skirt, continues that pattern, offering fans another example of how she has blended her established Hollywood profile with an increasingly visible presence in contemporary fashion.
What’s next for Alba
With her business ventures continuing through her board roles and creative projects, her acting career still active, and her personal life drawing continued public interest following her divorce and new relationship, Alba remains one of the more consistently visible figures spanning entertainment, fashion and business. Her latest social media post from New York City adds to a growing archive of style moments that have kept her fashion choices, alongside her broader career, a regular subject of coverage this year.
Business
Mutual fund NFOs: 5 new funds will open for subscription this week. Check dates and key details
Five new funds will open for subscription this week. Fund houses introduce new schemes to complete their bouquet of existing offerings. Here is a detailed break-up (Source: ACE MF).
-
Fashion2 days agoWeekend Open Thread: Brooks Brothers
-
News Videos7 days agoBig Money Is Entering XRP
-
Crypto World5 days agoGrayscale Files For Worldcoin ETF, WLD Registers Sharp Rise
-
Tech6 days agoSail Virtually Aboard The “Itanic” With IA-64 Emulator
-
Tech6 days ago
Turtle Beach Command Series KB7 review: a nifty screen-equipped gaming keyboard
-
NewsBeat6 days agoUnregistered fitter used Gas Safe logo on business flyers
-
Business4 days agoNew Jersey voter registration controversy explained: How 6,600 noncitizens got on the rolls, and what happens next
-
Entertainment5 days agoJohnny Depp’s R-Rated Gothic Cult Classic Gets New Release Ahead of Sydney Sweeney Remake
-
Crypto World4 days agoEthics, other provisions in crypto Clarity Act to be further discussed
-
Tech6 days agoWatch Flock Safety CEO Garrett Langley discuss the future of surveillance at TechCrunch Disrupt 2026
-
NewsBeat6 days agoShanghai science forum photos show China’s AI and robotics advances in rivalry with US
-
Crypto World6 days agoCircle’s President Sold Over 360,000 Shares, The Filings Explain Why
-
Tech6 days agoSubway Sandwich Computers Get a Second Life as Gaming Machines
-
Sports3 days ago2026 3M Open leaderboard: Scottie Scheffler finds putter in Round 1, sits three back
-
News Videos3 days agoThe Peugeot Family: How 200 Years of an “Old Money” Dynasty Died in A Boardroom
-
Fashion2 days ago16 Dresses for the High Summer Event
-
Tech7 days agoHow To Use Claude’s Reflect Dashboard And Learn When It’s Time To Touch Grass
-
Tech6 days agoThe 35 Best Board Games for Family Game Night
-
Entertainment6 days agoStephen Colbert Returns to Social Media After Late Show End
-
Crypto World6 days agoAndrew Cuomo joins OKX board as crypto exchange expands in U.S.

You must be logged in to post a comment Login